Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,251Revenue $M4,464Net Margin (%)7.4Altman Z-Score4.7
Enterprise Value $M16,366EPS $2.0Operating Margin %10.9Piotroski F-Score7
P/E(ttm)44.6Beneish M-Score-2.6Pre-tax Margin (%)9.4Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %-5.1Quick Ratio1.4Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %-10.3Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow158y-y EBITDA Growth Rate %64.3ROA % (ttm)5.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)10.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M173ROIC % (ttm)9.0Gross Margin Increase y-yY

Gurus Latest Trades with HSP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HSPJohn Rogers 2015-03-31 Sold Out -1.6%$60.63 - $88
($78.39)
$ 88.2713%Sold Out0
HSPVanguard Health Care Fund 2015-03-31 Sold Out -1.1%$60.63 - $88
($78.39)
$ 88.2713%Sold Out0
HSPMario Gabelli 2015-03-31 Add0.22%$60.63 - $88
($78.39)
$ 88.2713%Add 136.77%834,303
HSPJoel Greenblatt 2014-12-31 Sold Out -0.16%$48.12 - $62.84
($56.62)
$ 88.2756%Sold Out0
HSPJohn Rogers 2014-12-31 Reduce-0.08%$48.12 - $62.84
($56.54)
$ 88.2756%Reduce 5.02%2,311,309
HSPVanguard Health Care Fund 2014-12-31 Reduce-0.05%$48.12 - $62.84
($56.54)
$ 88.2756%Reduce 4.87%7,966,970
HSPMario Gabelli 2014-12-31 Add0.03%$48.12 - $62.84
($56.51)
$ 88.2756%Add 38.25%352,370
HSPJohn Rogers 2014-09-30 Reduce-0.45%$49.59 - $56.21
($53.12)
$ 88.2766%Reduce 22.28%2,433,369
HSPJoel Greenblatt 2014-09-30 Buy 0.16%$49.59 - $56.21
($53.12)
$ 88.2766%New holding313,242
HSPMario Gabelli 2014-09-30 Add0.01%$49.59 - $56.21
($53.12)
$ 88.2766%Add 24.71%254,870
HSPJohn Rogers 2014-06-30 Reduce-0.53%$42.14 - $52.41
($47.4)
$ 88.2786%Reduce 24.15%3,130,809
HSPMario Gabelli 2014-06-30 Add0.01%$42.14 - $52.41
($47.4)
$ 88.2786%Add 32.91%204,370
HSPBrian Rogers 2014-03-31 Sold Out -0.37%$40.89 - $45
($42.84)
$ 88.27106%Sold Out0
HSPJohn Rogers 2014-03-31 Reduce-0.28%$40.89 - $45
($42.84)
$ 88.27106%Reduce 11.62%4,127,850
HSPVanguard Health Care Fund 2014-03-31 Add0.18%$40.89 - $45
($42.83)
$ 88.27106%Add 22.69%8,375,170
HSPMario Gabelli 2014-03-31 Add0.01%$40.89 - $45
($42.84)
$ 88.27106%Add 30.68%153,770
HSPJohn Rogers 2013-12-31 Add0.12%$38.53 - $42.19
($40.25)
$ 88.27119%Add 5.28%4,670,630
HSPRichard Pzena 2013-09-30 Sold Out -0.27%$38.45 - $42.03
($39.88)
$ 88.27121%Sold Out0
HSPJohn Rogers 2013-09-30 Reduce-0.23%$38.45 - $42.03
($39.88)
$ 88.27121%Reduce 7.79%4,436,305
HSPJohn Rogers 2013-06-30 Add0.34%$30.57 - $38.31
($33.81)
$ 88.27161%Add 12.97%4,811,105
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HSP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HSP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stober Matthew RSVP, Operations 2015-03-02Sell21,833$87.490.89view
Stober Matthew RSVP, Operations 2015-02-27Sell25,338$87.470.91view
Werner Thomas ESVP, Finance & CFO 2015-02-17Sell1,566$87.351.05view
Werner Thomas ESVP, Finance & CFO 2015-01-15Sell10,000$61.5643.39view
Stober Matthew RSVP, Operations 2015-01-12Sell2,000$61.842.83view
Werner Thomas ESVP, Finance & CFO 2014-12-15Sell10,000$60.8645.04view
Hoffman Richard JCVP, Controller & CAO 2014-12-02Sell21,850$60.3246.34view
SOKOLOV JACQUE JDirector 2014-11-28Sell7,547$60.3246.34view
Yoskowitz Marc JSVP, Strategy & Corporate Dev 2014-11-25Sell11,523$59.9347.29view
SMITH BRIAN JSVP and Special Counsel 2014-11-24Sell185,700$59.3148.83view

Press Releases about HSP :

    Quarterly/Annual Reports about HSP:

    News about HSP:

    Articles On GuruFocus.com

    More From Other Websites
    10 companies with the biggest earnings surprises May 22 2015
    How biotechs are affecting J&J's business May 20 2015
    Hospira, Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to... May 20 2015
    Hospira, Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to... May 20 2015
    20 / 05 / 2015 : THERADIAG AND HOSPIRA SIGN A PARTNERSHIP AGREEMENT May 20 2015
    Drug maker Endo strikes again with $8bn bid for US rival May 18 2015
    Barclays: Pfenex Is Worth $28/Share May 18 2015
    Hospira–Pfizer Deal Update: Shareholder Approval, 2nd Request May 14 2015
    Hospira Shareholders Approve Merger of Hospira and Pfizer at Special Meeting May 13 2015
    Hospira Shareholders Approve Merger of Hospira and Pfizer at Special Meeting May 13 2015
    HOSPIRA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 13 2015
    HOSPIRA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 12 2015
    How the Mylan Bid Stacks Up to Similar Transactions May 11 2015
    Weak Q1 Earnings Have Some Investors Worried.......Should You Be? May 04 2015
    HOSPIRA INC Financials May 01 2015
    Hospira Statement On FDA's Final Biosimilar Guidance Documents May 01 2015
    Mylan Shareholders Well Placed in the Mylan–Teva Deal Apr 30 2015
    10-Q for Hospira, Inc. Apr 30 2015
    Mylan Bumps Up Offer for Perrigo Apr 29 2015
    The Perrigo–Mylan Proposal Faces some Big Hurdles Apr 29 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK